Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArc Minerals Regulatory News (ARCM)

Share Price Information for Arc Minerals (ARCM)

Share Price is delayed by 15 minutes
Get Live Data
0.575    -0.135 (-19.01%)
Bid:
0.55
Ask:
0.60
Spread: 0.05 (9.091%)
Market Cap: £14.14m
ARCM Live PriceLast checked at - London Stock Exchange

Intraday Arc Minerals Share Chart

Anglo JV Payment

28 Nov 2024 07:00

RNS Number : 9103N
Arc Minerals Limited
28 November 2024
 

28 November 2024, 07:00 UTC

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (MAR) as in force in the United Kingdom pursuant to the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service (RIS), this inside information will be in the public domain.

Arc Minerals Ltd

('Arc' or the 'Company')

Anglo JV Payment

 

Arc Minerals (LSE: ARCM) is pleased to announce that it has received further payment of USD 1 million under the Joint Venture with a subsidiary of Anglo American ("Anglo JV").

 

The commercial terms of the Anglo JV were set out in the Company's announcement of 12 May 2022. All payments under the agreement are receivable by Arc on behalf of its subsidiary Unico Minerals Ltd, with Arc retaining 67% of amounts received and the balance attributable to its fellow Unico shareholder.

The Directors of Arc are solely and entirely responsible for the content of this announcement. Neither Anglo American nor any other person, accepts responsibility for the adequacy or accuracy of this news release.

Unico Minerals Ltd is a 67%-owned subsidiary of Arc.

 

For further information contact:

Arc Minerals Ltd

Nick von Schirnding (Executive Chairman)

 

c/o Benchmark Communications

Zeus (Nominated Adviser & Joint Broker)

Katy Mitchell/Harry Ansell

Tel: +44 (0) 20 3829 5000

Shard Capital Partners LLP (Joint Broker)

Damon Heath

Tel: +44 (0) 20 7186 9952

For more information, visit www.arcminerals.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBLBDBDBDDGSR
Date   Source Headline
16th Mar 20217:00 amRNSSurrender of Share Options
12th Mar 20213:15 pmRNSOption Exercise and TR1 Notification
10th Mar 20213:53 pmRNSMedia Speculation
5th Mar 20217:00 amRNSAppointment of Financial Adviser
2nd Mar 20212:57 pmRNSOption Exercise
23rd Feb 20217:00 amRNSChange of Accounting Reference Date
11th Feb 20213:59 pmRNSOption Exercise
10th Feb 20217:00 amRNSInvestor Conference Call
21st Jan 20217:00 amRNSHolding(s) in Company
20th Jan 202111:55 amRNSInterim Results
14th Jan 20212:06 pmRNSSecond Price Monitoring Extn
14th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 20219:05 amRNSSecond Price Monitoring Extn
13th Jan 20219:00 amRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSUpdate on Exclusivity Agreement
12th Jan 20217:00 amRNSPlacing with UK Institution
23rd Dec 20205:03 pmRNSConvertible Loan Note Facility Extension
15th Dec 20204:32 pmRNSGrant of Options
15th Dec 20204:27 pmRNSDelay in Publication of Interim Results
15th Dec 20203:08 pmRNSFirst Phase of Proof of Concept Study Completed
9th Dec 20204:30 pmRNSFurther Drill Results from Fwiji and Muswema
9th Dec 20204:05 pmRNSFurther drill results from Fwiki and Muswema
7th Dec 202011:20 amRNSAnglo American Update
4th Dec 20202:06 pmRNSSecond Price Monitoring Extn
4th Dec 20202:00 pmRNSPrice Monitoring Extension
26th Nov 20205:09 pmRNSResignation of Non-executive Director
24th Nov 20202:05 pmRNSSecond Price Monitoring Extn
24th Nov 20202:00 pmRNSPrice Monitoring Extension
24th Nov 202011:05 amRNSSecond Price Monitoring Extn
24th Nov 202011:00 amRNSPrice Monitoring Extension
24th Nov 20209:05 amRNSSecond Price Monitoring Extn
24th Nov 20209:00 amRNSPrice Monitoring Extension
5th Nov 20205:30 pmRNSResult of Annual General Meeting
30th Oct 20207:00 amRNSDrill Results Confirm Fwiji as a Major Target
29th Oct 20207:00 amRNSBoard Appointment
12th Oct 20204:34 pmRNS2020 Annual Report and Notice of AGM
30th Sep 202011:27 amRNSDelay in Publication of 2020 Annual Report
21st Sep 20206:05 pmRNSBlock Admission Application
21st Sep 20207:00 amRNSDrilling and Assay update
9th Sep 20205:21 pmRNSWarrant Exercise
24th Aug 20208:34 amRNSBoard Change
14th Aug 20202:09 pmRNSWarrant Exercise
11th Aug 202011:44 amRNSSale of Sturec Update
6th Aug 20202:46 pmRNSWarrant Exercise
4th Aug 20207:00 amRNSWarrant Exercise
3rd Aug 20202:00 pmRNSPrice Monitoring Extension
3rd Aug 202011:00 amRNSPrice Monitoring Extension
22nd Jul 20201:10 pmRNSInvestor Conference Call
14th Jul 20204:41 pmRNSSecond Price Monitoring Extn
14th Jul 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.